Basics Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. IPO Date: December 31, 1981 Sector: Healthcare Industry: Pharma Market Cap: $99.03B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 0.92% Avg Daily Range (30 D): $0.57 | 1.20% Avg Daily Range (90 D): $0.75 | 1.42% Institutional Daily Volume Avg Daily Volume: 9.37M Avg Daily Volume (30 D): 11.49M Avg Daily Volume (90 D): 11.05M Trade Size Avg Trade Size (Sh.): 182 Avg Trade Size (Sh.) (30 D): 108 Avg Trade Size (Sh.) (90 D): 98 Institutional Trades Total Inst.Trades: 123,181 Avg Inst. Trade: $4.94M Avg Inst. Trade (30 D): $6.42M Avg Inst. Trade (90 D): $6.51M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 22 Market Closing Trades Avg Closing Trade: $57.92M Avg Closing Trade (30 D): $124.24M Avg Closing Trade (90 D): $125.41M Avg Closing Volume: 1.08M     News Jun 21, 2025 @ 10:20 AM ICPO Foundation ist Co-Founder der RLT Angels Asso... Source: N/A Jun 21, 2025 @ 10:20 AM ICPO Foundation co-founded the RLT Angels Associat... Source: N/A Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor Jun 16, 2025 @ 8:25 AM 2 Beaten-Down Dividend Stocks to Buy Right Now Source: Prosper Junior Bakiny Jun 10, 2025 @ 9:55 PM Philochem AG Announces the Licensing of Worldwide ... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.69 $1.21 $.04 Diluted EPS $2.68 $1.2 $.04 Revenue $ 47.64B $ 11.2B $ 12.34B Gross Profit $ 33.57B $ 8.17B $ 7.53B Net Income / Loss $ 5.44B $ 2.46B $ 76M Operating Income / Loss $ 6.11B $ 2.97B $ 175M Cost of Revenue $ 14.07B $ 3.03B $ 4.81B Net Cash Flow $ 1.54B $ 528M $ 2.45B PE Ratio 17.50